Subtype
Glioma
CI-CAN-00000935Explore in graph →
Non-malignant787 active trials5 approved drugs147 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000935Explore in graph →
Clinical trials
2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03741244 | TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT | unknown | Phase 2 | 211 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02520635 | Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients | unknown | — | 180 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT03392545 | Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)(InSituVac1) | unknown | Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT04004975 | Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib | unknown | Phase 1 / Phase 2 | 50 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT03971812 | Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma(GLIOMANOID) | unknown | — | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03916757 | V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer(GBM) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03690570 | Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015(GlioUnder5) | unknown | — | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Apr 4, 2019 | clinicaltrials |
| NCT03869242 | NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM(NovoTTF-200A) | unknown | N/A | 60 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03687034 | A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma | unknown | Phase 1 | 21 | Leaf Vertical Inc.INDUSTRY | 0 | Feb 26, 2019 | clinicaltrials |
| NCT02209428 | A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas | unknown | Phase 2 | 54 | Huashan HospitalOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT03091270 | ZOOMit-fMRI Identifies Motor Functional Cortex | unknown | — | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 16, 2019 | clinicaltrials |
| NCT03780569 | TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | unknown | N/A | 10 | NovoCure Ltd.INDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03642080 | MRI Predictors of Response to Tumor Treating Fields | unknown | — | 48 | New York Presbyterian Brooklyn Methodist HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT02652897 | Hemostasis Alterations in Neurosurgical Patients(ABCD) | unknown | — | 120 | Santiago R. Leal-NovalOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT03746288 | To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) | unknown | Phase 2 | 60 | CANbridge Life Sciences Ltd.INDUSTRY | 0 | Nov 19, 2018 | clinicaltrials |
| NCT03716986 | Multimodal Imaging of Hypoxia in Gliomas(GLIOXYMAGE) | unknown | N/A | 20 | University Hospital, CaenOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT03641391 | Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction | unknown | N/A | 300 | Huashan HospitalOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03631836 | Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma(MARELLE01) | unknown | Phase 1 | 34 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03633552 | Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma | unknown | Phase 3 | 62 | Mashhad University of Medical SciencesOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT03631823 | Gut Microbiota and Glioblastoma Multiforme Prognosis | unknown | — | 200 | Huashan HospitalOTHER | 0 | Aug 15, 2018 | clinicaltrials |
| NCT03607643 | A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | unknown | Phase 1 / Phase 2 | 160 | Leaf Vertical Inc.INDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT02233049 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication(BIOMEDE) | unknown | Phase 2 | 250 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT02345824 | Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma | unknown | Phase 1 | 3 | University of VirginiaOTHER | 1 | Jun 7, 2018 | clinicaltrials |
| NCT02945826 | uPAR-PET/MRI in Glioblastoma Multiforme | unknown | Phase 2 | 35 | Rigshospitalet, DenmarkOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT02840123 | Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines | unknown | Phase 1 | 10 | Fundació Sant Joan de DéuOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT01765088 | A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT02629757 | A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas(β-elemene) | unknown | Phase 3 | 100 | Sun Yat-sen UniversityOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT02910804 | IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma | unknown | Early Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03401866 | Multi-site Validation and Application of a Consensus DSC-MRI Protocol | unknown | N/A | 80 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03390062 | A Study of Apatinib in Recurrent or Recurrent High-grade Glioma | unknown | Phase 2 | 30 | West China HospitalOTHER | 0 | Jan 4, 2018 | clinicaltrials |
| NCT03370926 | FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy(IMAGG) | unknown | — | 30 | University Hospital, BrestOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT02941302 | Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study | unknown | N/A | 50 | General Hospital of Ningxia Medical UniversityOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT03294486 | Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients(ONCOVIRAC) | unknown | Phase 1 / Phase 2 | 78 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01759810 | Proteome-based Personalized Immunotherapy of Glioblastoma | unknown | Phase 2 / Phase 3 | 60 | NeuroVita ClinicOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT03152708 | CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma | unknown | — | 62 | CANbridge Life Sciences Ltd.INDUSTRY | 0 | Sep 21, 2017 | clinicaltrials |
| NCT00575796 | Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs) | unknown | Phase 2 | 50 | The Hospital for Sick ChildrenOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT02597335 | Non Invasive Detection of IDH1/2 Mutation in Gliomas(IDASPE) | unknown | N/A | 40 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT03225963 | Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents. | unknown | — | 60 | Taichung Veterans General HospitalOTHER | 1 | Jul 24, 2017 | clinicaltrials |
| NCT03225300 | Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation | unknown | N/A | 120 | Taichung Veterans General HospitalOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT03212235 | Hypofractionated Radiation Therapy for Glioblastoma | unknown | Phase 2 | 58 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT02848794 | Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma | unknown | Phase 1 / Phase 2 | 40 | The First People's Hospital of LianyungangOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT03180697 | The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas(APT) | unknown | — | 100 | Zhujiang HospitalOTHER | 1 | Jun 8, 2017 | clinicaltrials |
| NCT01801371 | 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma(GRGDG) | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT02520882 | 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT03102203 | Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging | unknown | — | 350 | Jinling Hospital, ChinaOTHER | 1 | Apr 5, 2017 | clinicaltrials |
| NCT03058198 | The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma | unknown | N/A | 40 | Huashan HospitalOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT00330109 | Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology | unknown | N/A | 113 | AHS Cancer Control AlbertaOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT02119338 | 5-ALA in Recurrent Glioma | unknown | N/A | 60 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02939378 | Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study(KGDinrGBM) | unknown | Phase 1 / Phase 2 | 60 | Song LinOTHER | 1 | Oct 20, 2016 | clinicaltrials |
| NCT02937844 | Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme | unknown | Phase 1 | 20 | Beijing Sanbo Brain HospitalOTHER | 1 | Oct 19, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jul 23, 2019source: clinicaltrials